Entries by Marie Bolin

Follow the money

On December 9, this year’s digital Sweden BIO Summit was livestreamed from Grand Hotel in Stockholm. Our CEO Christina Lloyd Östberg was invited as one of the speakers in the session “Follow the money”.  Helena Strigård, CEO of SwedenBIO, interviews Christina about the small life science company’s challenges and crossroads ahead of the initial public […]

Roadmap to IPO

Pharmiva has recently raised just over 11 MSEK. The money will be used to continue building the organization, prepare the market and start a clinical study in bacterial vaginosis. The plan is to go public in April next year, and to achieve this, additional financing is needed. This is stated by our CEO Christina Östberg […]

How to grow a startup

From global big pharma and Novo Nordisk to the startup Pharmiva AB. In the latest episode of Brännpunkt Life Science, CEO Christina Östberg Lloyd shares the lessons from her colorful career and talks about: What skills are required to succeed in a startup What is needed in order to grow Life Science companies in the […]

from big pharma to pre-ipo start up

CEO Christina Östberg Lloyd will be one of the speakers in the “Follow the money” session at SwedenBIO Summit on December 9. In an interview by SwedenBIO, Christina talks about her first few weeks as CEO of Pharmiva after eleven years as Medical and Clinical Director at Novo Nordisk. – For the first three to […]

Dare to talk about vaginal health

CEO and gynaecologist Christina Östberg Llloyd wants to encourage women to break existing tabus and speak up about the importance of vaginal health. Bacterial vaginosis is the most common vaginal infection causes foul-smelling discharges. Untreated BV can cause stigmatisation and suffering among women, but few women contact healthcare – because they feel embarrassed. Click on […]

Pharmiva will cure bacterial vaginosis – without antibiotics

Insikt Medicin interviews our CEO Christina Östberg Lloyd about her new assignment, the benefits of the technology platform Venerol® and the possibilities in future, effectively treating bacterial vaginosis without the risk of antimicrobial resistance. Please read the full article here    

Christina Östberg Lloyd joins Pharmiva as new CEO

We are very pleased to announce that Christina Östberg Lloyd has started her new assignment as Pharmiva’s new CEO. Christina is a MD, specialized within gynecology and obstetrics, and has a long experience from leading positions in international life sciences companies (Novo Nordisk Scandinavia and Ferring Pharmaceuticals). Also, she holds the position as chairman of […]

Pharmiva receives ISO certification

Pharmiva received ISO certification on 29th October 2019, for the quality management system for medical devices that fulfils the requirements of SS-EN ISO 13485:2016 with respect to design, production, marketing, and sales of products for women´s health.